Abstract
The effect of flumazenil, a benzodiazepine antagonist, on hepatic encephalopathy was studied in rabbits with acute hepatic failure induced by a two-stage liver devascularization procedure. The rabbits were randomized for treatment with 5 mg/kg of flumazenil or the placebo. The drug was administered at two easily recognizable time points in the course of the encephalopathy: first, when the righting reflex was disturbed, and second, when the animal could no longer achieve to the sitting position. The response after flumazenil did not differ from that after the placebo, as measured by clinical evaluation and automated EEG analysis. Furthermore, the progression of the encephalopathy, as measured by the survival time after the first injection, was not affected by flumazenil.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bansky, G., Meier, P. J., Ziegler, W. H., Walser, H., Schmid, M., and Huber, M. (1985). Reversal of hepatic coma by benzodiazepine antagonist Rol5-1788.Lancet 1: 1324–1325.
Bansky, G., Meier, P. J., Riederer, E., Walser, H., Ziegler, W. H., and Schmid, M. (1989). Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.Gastroenterology 97: 44–50.
Baraldi, M., and Zeneroli, M. L. (1982). Experimental hepatic encephalopathy: Changes in the binding of gamma-aminobutyric acid.Science 216: 427–429.
Baraldi, M., Zeneroli, M. L., Ventura, E., Penne, A., Pinelli, G., Ricci, P., and Santi, M. (1984). Super-sensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: Reversal by a benzodiazepine antagonist.Clin. Sci. 67: 167–175.
Basile, A. S., and Gammal, S. J. (1988). Evidence for the involvement of the benzodiazepine receptor complex in hepatic encephalopathy. Implications for treatment with benzodiazepine receptor antagonists.Clin. Neuropharm. 11: 401–422.
Bassett, M. L., Mullen, K. D., Skolnick, P., and Jones, E. A. (1987). Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABA-A-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.Gastroenterology 93: 1069–1077.
Bitterman, H., Lefer, D. J., and Lefer, A. M. (1987). Beneficial actions of Ro 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.Meth. Find. Exp. Clin. Pharmacol. 9: 341–347.
Brachtel, D., and Wernze, H. (1988). Renin-angiotensin system, blood pressure homeostasis and renal function in galactosamine-induced fulminant hepatic failure in the guinea pig.Clin. Physiol. Biochem. 6: 95–105.
Braestrup, C., Nielsen, M., Honoré, T., Jensen, L.H., and Petersen, E. N. (1983). Benzodiazepine ligands with positive and negative efficacy.Neuropharmacology 22: 1451–1457.
Burke, D.A. (1988). Reversal of hepatic coma with flumazenil with improvement in visual evoked potentials.Lancet 2: 505–506.
Butterworth, R. F., Lavoie, J., Giguère, J. F., and Pomier-Layrargues, G. (1988). Affinities anddensities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.Hepatology 8: 1084–1088.
Ferenci, P., Zieve, L., Ebner, J., Zimmermann, Ch., and Rzepczynski, D. (1987). Postsynaptic gammaaminobutyric acid receptors in hepatic coma following portacaval shunt and hepatic artery ligation in the rat.Metab. Brain Dis. 2: 195–200.
Ferenci, P., Grimm, G., Meryn, S., and Gangl, A. (1989). Successful long-term treatment of portalsystemic encephalopathy by the benzodiazepine antagonist flumazenil.Gastroenterology 96: 240–243.
Fick, T. E., Schalm, S. W., and De Vlieger, M. (1987). A surgical model of fulminant hepatic failure in the rabbit: Different effects of end-to-side versus small-diameter side-to-side portacaval shunt.Eur. Surg. Res. 19: 276–282.
Gammal, S. H., Jones, E. A., Bassett, M. L., Mullen, K. D., Geller, D., and Skolnick, P. (1988). Antagonists of the GABA/benzodiazepine receptor complex ameliorate hepatic encephalopathy in two models of fulminant hepatic failure. In Soeters, P. B., Wilson, J. H. P., Meijer, A. J., and Holm, E. (eds.),Advances in Ammonia Metabolism and Hepatic Encephalopathy, Proceedings of the 6th International Symposium on ammonia, Vaalsbroek Castle, The Netherlands, 27–29 April 1987, Elsevier, Amsterdam, pp. 325–332.
Gogolàk, G., Stumf, Ch., and Huck, S. (1985). Differentiation of drug-induced rhythmical activities in the rabbit's brain by a benzodiazepine antagonist.Arzneim-Forsch. 35: 233–236.
Grimm, G., Katzenschlager, R., Schneeweiss, B., Lenz, K., Ferenci, P., Madl, C., Laggner, A. N., and Gangl, A. (1988). Improvement of hepatic encephalopathy treated with flumazenil.Lancet 2: 1392–1394.
Grün, M., Liehr, H., and Rasenack, U. (1976). Significance of endotoxaemia in experimental “galactosamine-hepatitis” in the rat.Acta Hepato-Gastroenterol. 23: 64–81.
Jones, E. A., Schafer, D. F., Ferenci, P., and Pappas, S. C. (1984). The GABA hypothesis of the pathogenesis of hepatic encephalopathy: Current status.Yale J. Biol. Med. 57: 301–316.
Jones, E. A., Mullen, K. D., and Gammal, S. H. (1987). Hepatic encephalopathy. In Arias, I. M., Frenkel, M., and Wilson, J. H. P. (eds.),The Liver Annual 6, Elsevier, Amsterdam, pp. 396–415.
Klotz, U., and Walker, S. (1989). Flumazenil and hepatic encephalopathy.Lancet 1: 155–156.
Maddison, J. E., Dodd, P. R., Morrison, M., Johnston, G. A. R., and Farrell, G. C. (1987a). Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy.Hepatology 7: 621–628.
Maddison, J. E., Dodd, P. R., Johnston, A. R., and Farrell, G. C. (1987b). Brain gamma-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma gamma-aminobutyric acid-like activity.Gastroenterology 93: 1062–1068.
Pappas, S. C., Levy, G., Gordon, V. P., Nakatsukasa, H., and Martin, P. (1988). The GABA hypothesis of hepatic encephalopathy: Further studies in multiple animal models. In Soeters, P. B., Wilson, J. H. P., Meijer, A. J., and Holm, E. (eds.),Advances in Ammonia Metabolism and Hepatic Encephalopathy, Proceedings of the 6th International Symposium on ammonia, Vaalsbroek Castle, The Netherlands, 27–29 April 1987, Elsevier, Amsterdam, pp. 259–264.
Rössle, M., Deckert, J., and Jones, E. A. (1989). Autoradiographic analysis of GABA-benzodiazepine receptors in an animal model of acute hepatic encephalopathy.Hepatology 10: 143–147.
Roy, S., Pomier-Layrargues, G., Butterworth, R. F., and Huet, P. M. (1988). Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors.Hepatology 8: 845–849.
Rzepczynski, D., Zieve, L., Lindblad, S., and LaFontaine, D. (1986). In vivo studies of GABAergic effects in experimental hepatic encephalopathy.Hepatology 6: 902–905.
Schafer, D. F., Fowler, J. M., Munson, P. J., Thakur, A. K., Waggoner, J. G., and Jones, E. A. (1983). Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.J. Lab. Clin. Med. 102: 870–880.
Scollo-Lavizzari, G., and Steinmann, E. (1985). Reversal of hepatic coma by benzodiazepine antagonist Ro15-1788.Lancet 1: 1324.
Sutherland, L. R., and Minuk, G. Y. (1988). Ro15-1788 and hepatic failure.Ann. Intern. Med. 108: 158.
Svedberg, A., Maddock, S., and Drury, D. D. (1938). The effect of total removal of the liver in the rabbit.Am. J. Physiol. 121: 209–214.
Thompson, J. S., Schafer, D. F., Schafer, G. J., and Hodgson, F. E. (1985). Gamma-aminobutyric acid plasma levels and brain binding in eck fistula dogs.J. Surg. Res. 38: 143–148.
Van der Rijt, C. C. D., Schalm, S. W., De Groot, G. H., and De Vlieger, M. (1984). Objective measurement of hepatic encephalopathy by means of automated EEG analysis.Electroenceph. Clin. Neurophysiol. 57: 423–426.
Van der Rijt, C. C. D., Schalm, S. W., Meulstee, J., and Stijnen, Th. (1989). Flumazenil therapy for hepatic encephalopathy: A double-blind cross-over study.Hepatology 10: 590 (abstract).
Walker, J. E. (1983). Glutamate, GABA and CNS disease: a review.Neurochem. Res. 8: 521–550.
Zeneroli, M. L., and Baraldi, M. (1988). Increased functional activity of the GABA-benzodiazepine receptor unit in a rat model of hepatic encephalopathy: Pharmacological evidence.Hepatology 8: 1388.
Zieve, L., Ferenci, P., Rzepczynski, D., Ebner, J., and Zimmermann, C. (1987). A Benzodiazepine antagonist does not alter the course of experimental hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.Metab. Brain Dis. 2: 201–205.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Rijt, C.C.D., de Knegt, R.J., Schalm, S.W. et al. Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit. Metab Brain Dis 5, 131–141 (1990). https://doi.org/10.1007/BF00999840
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00999840